Literature DB >> 22421514

MicroRNAs and the glomerulus.

Mitsuo Kato1, Jung Tak Park, Rama Natarajan.   

Abstract

MicroRNAs (miRNAs) are short non-coding RNAs regulating gene expression at the post-transcriptional level by blocking translation or promoting cleavage of their target mRNAs. Increasing evidence shows that miRNAs play central roles in gene transcription, signal transduction and pathogenesis of human diseases. Diabetic nephropathy (DN) is a severe microvascular complication that can lead to end-stage renal disease. Increased expansion (hypertrophy) and accumulation of extracellular matrix (ECM) proteins such as collagen (fibrosis) in the glomerular mesangium along with glomerular podocyte dysfunction are major features of DN. Profiling of miRNAs and study\ of their functions in renal glomeruli can provide critical new information to advance our knowledge of DN as well as other kidney diseases and thereby uncover much needed new therapeutic targets. In this review, we summarize the biogenesis of miRNAs and their functions in the glomerulus, with particular emphasis on glomerular mesangial cells and podocytes related to the pathogenesis of DN.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22421514      PMCID: PMC3334455          DOI: 10.1016/j.yexcr.2012.02.034

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  78 in total

1.  High glucose down-regulates miR-29a to increase collagen IV production in HK-2 cells.

Authors:  Bin Du; Li-Ming Ma; Mian-Bo Huang; Hui Zhou; Hui-Lin Huang; Peng Shao; Yue-Qin Chen; Liang-Hu Qu
Journal:  FEBS Lett       Date:  2010-01-12       Impact factor: 4.124

2.  miR-21 and miR-214 are consistently modulated during renal injury in rodent models.

Authors:  Laura Denby; Vasudev Ramdas; Martin W McBride; Joe Wang; Hollie Robinson; John McClure; Wendy Crawford; Ruifang Lu; Dianne Z Hillyard; Raya Khanin; Reuven Agami; Anna F Dominiczak; Claire C Sharpe; Andrew H Baker
Journal:  Am J Pathol       Date:  2011-05-31       Impact factor: 4.307

3.  The delta-crystallin enhancer-binding protein delta EF1 is a repressor of E2-box-mediated gene activation.

Authors:  R Sekido; K Murai; J Funahashi; Y Kamachi; A Fujisawa-Sehara; Y Nabeshima; H Kondoh
Journal:  Mol Cell Biol       Date:  1994-09       Impact factor: 4.272

4.  SIP1, a novel zinc finger/homeodomain repressor, interacts with Smad proteins and binds to 5'-CACCT sequences in candidate target genes.

Authors:  K Verschueren; J E Remacle; C Collart; H Kraft; B S Baker; P Tylzanowski; L Nelles; G Wuytens; M T Su; R Bodmer; J C Smith; D Huylebroeck
Journal:  J Biol Chem       Date:  1999-07-16       Impact factor: 5.157

5.  Smad proteins bind a conserved RNA sequence to promote microRNA maturation by Drosha.

Authors:  Brandi N Davis; Aaron C Hilyard; Peter H Nguyen; Giorgio Lagna; Akiko Hata
Journal:  Mol Cell       Date:  2010-08-13       Impact factor: 17.970

Review 6.  MicroRNA control of signal transduction.

Authors:  Masafumi Inui; Graziano Martello; Stefano Piccolo
Journal:  Nat Rev Mol Cell Biol       Date:  2010-03-10       Impact factor: 94.444

7.  Conserved MicroRNA miR-8/miR-200 and its target USH/FOG2 control growth by regulating PI3K.

Authors:  Seogang Hyun; Jung Hyun Lee; Hua Jin; JinWu Nam; Bumjin Namkoong; Gina Lee; Jongkyeong Chung; V Narry Kim
Journal:  Cell       Date:  2009-12-11       Impact factor: 41.582

8.  E-cadherin expression is regulated by miR-192/215 by a mechanism that is independent of the profibrotic effects of transforming growth factor-beta.

Authors:  Bo Wang; Michal Herman-Edelstein; Philip Koh; Wendy Burns; Karin Jandeleit-Dahm; Anna Watson; Moin Saleem; Gregory J Goodall; Stephen M Twigg; Mark E Cooper; Phillip Kantharidis
Journal:  Diabetes       Date:  2010-04-14       Impact factor: 9.461

Review 9.  The extracellular matrix in diabetic nephropathy.

Authors:  F N Ziyadeh
Journal:  Am J Kidney Dis       Date:  1993-11       Impact factor: 8.860

10.  Glucose up-regulates thrombospondin 1 gene transcription and transforming growth factor-beta activity through antagonism of cGMP-dependent protein kinase repression via upstream stimulatory factor 2.

Authors:  Shuxia Wang; Jim Skorczewski; Xu Feng; Lin Mei; Joanne E Murphy-Ullrich
Journal:  J Biol Chem       Date:  2004-06-07       Impact factor: 5.157

View more
  26 in total

Review 1.  MicroRNAs: potential regulators of renal development genes that contribute to CAKUT.

Authors:  April K Marrone; Jacqueline Ho
Journal:  Pediatr Nephrol       Date:  2013-09-03       Impact factor: 3.714

Review 2.  MicroRNAs in diabetic nephropathy: functions, biomarkers, and therapeutic targets.

Authors:  Mitsuo Kato; Rama Natarajan
Journal:  Ann N Y Acad Sci       Date:  2015-04-15       Impact factor: 5.691

Review 3.  Emerging roles for miRNAs in the development, diagnosis, and treatment of diabetic nephropathy.

Authors:  Johanna K DiStefano; Matthew Taila; M Lucrecia Alvarez
Journal:  Curr Diab Rep       Date:  2013-08       Impact factor: 4.810

4.  Long non-coding RNA ENSMUST00000147869 protects mesangial cells from proliferation and fibrosis induced by diabetic nephropathy.

Authors:  Min Wang; Di Yao; Suyu Wang; Qin Yan; Weiping Lu
Journal:  Endocrine       Date:  2016-04-15       Impact factor: 3.633

5.  Stability of miRNA in human urine supports its biomarker potential.

Authors:  Christine Mall; David M Rocke; Blythe Durbin-Johnson; Robert H Weiss
Journal:  Biomark Med       Date:  2013-08       Impact factor: 2.851

Review 6.  MicroRNAs and diabetic complications.

Authors:  Rama Natarajan; Sumanth Putta; Mitsuo Kato
Journal:  J Cardiovasc Transl Res       Date:  2012-05-03       Impact factor: 4.132

7.  High glucose enhances microRNA-26a to activate mTORC1 for mesangial cell hypertrophy and matrix protein expression.

Authors:  Nirmalya Dey; Amit Bera; Falguni Das; Nandini Ghosh-Choudhury; Balakuntalam S Kasinath; Goutam Ghosh Choudhury
Journal:  Cell Signal       Date:  2015-03-20       Impact factor: 4.315

8.  Repression of let-7 by transforming growth factor-β1-induced Lin28 upregulates collagen expression in glomerular mesangial cells under diabetic conditions.

Authors:  Jung Tak Park; Mitsuo Kato; Linda Lanting; Nancy Castro; Bo Young Nam; Mei Wang; Shin-Wook Kang; Rama Natarajan
Journal:  Am J Physiol Renal Physiol       Date:  2014-10-29

Review 9.  MicroRNAs: potential mediators and biomarkers of diabetic complications.

Authors:  Mitsuo Kato; Nancy E Castro; Rama Natarajan
Journal:  Free Radic Biol Med       Date:  2013-06-12       Impact factor: 7.376

10.  TGF-β induces acetylation of chromatin and of Ets-1 to alleviate repression of miR-192 in diabetic nephropathy.

Authors:  Mitsuo Kato; Varun Dang; Mei Wang; Jung Tak Park; Supriya Deshpande; Swati Kadam; Armen Mardiros; Yumei Zhan; Peter Oettgen; Sumanth Putta; Hang Yuan; Linda Lanting; Rama Natarajan
Journal:  Sci Signal       Date:  2013-06-04       Impact factor: 8.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.